Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ann Eldred, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 37082
Birmingham, Alabama, United States
- Site Reference Id/investigator# 26762
Gainesville, Florida, United States
- Site Reference Id/investigator# 28529
Orlando, Florida, United States
- Site Reference Id/investigator# 26748
Atlanta, Georgia, United States
- Site Reference Id/investigator# 37582
New Orleans, Louisiana, United States
- Site Reference Id/investigator# 39973
Baltimore, Maryland, United States
- Site Reference Id/investigator# 26769
Boston, Massachusetts, United States
- Site Reference Id/investigator# 26768
Detroit, Michigan, United States
- Site Reference Id/investigator# 26747
Kansas City, Missouri, United States
- Site Reference Id/investigator# 26749
Akron, Ohio, United States
- Site Reference Id/investigator# 26751
Cincinnati, Ohio, United States
- Site Reference Id/investigator# 26765
Columbus, Ohio, United States
- Site Reference Id/investigator# 28528
Oklahoma City, Oklahoma, United States
- Site Reference Id/investigator# 26763
Portland, Oregon, United States
- Site Reference Id/investigator# 28526
Charlottesville, Virginia, United States
- Site Reference Id/investigator# 26758
Seattle, Washington, United States
- Site Reference Id/investigator# 40382
Madison, Wisconsin, United States
- Site Reference Id/investigator# 26759
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 31 May 2012
- Completion
- 31 May 2012
- Last update posted
- 13 Aug 2013
- Registered enrollment
- 61
- Registry id
- NCT01134315
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.